These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1303 related articles for article (PubMed ID: 10321661)

  • 1. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.
    Mussack T; Briegel J; Schelling G; Biberthaler P; Jochum M
    Clin Chem Lab Med; 2005; 43(3):259-68. PubMed ID: 15843228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.
    Oppert M; Schindler R; Husung C; Offermann K; Gräf KJ; Boenisch O; Barckow D; Frei U; Eckardt KU
    Crit Care Med; 2005 Nov; 33(11):2457-64. PubMed ID: 16276166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.
    Huh JW; Choi HS; Lim CM; Koh Y; Oh YM; Shim TS; Lee SD; Kim WS; Kim DS; Hong SB
    Respirology; 2011 Oct; 16(7):1088-95. PubMed ID: 21726354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Feb; 10(2):81-7. PubMed ID: 15817428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Jan; 10(1):11-7. PubMed ID: 15737948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock.
    Oppert M; Reinicke A; Gräf KJ; Barckow D; Frei U; Eckardt KU
    Intensive Care Med; 2000 Dec; 26(12):1747-55. PubMed ID: 11271081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of late septic shock with supraphysiologic doses of hydrocortisone.
    Bollaert PE; Charpentier C; Levy B; Debouverie M; Audibert G; Larcan A
    Crit Care Med; 1998 Apr; 26(4):645-50. PubMed ID: 9559600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
    Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
    Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial.
    Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ
    Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.
    Boerma EC; Koopmans M; Konijn A; Kaiferova K; Bakker AJ; van Roon EN; Buter H; Bruins N; Egbers PH; Gerritsen RT; Koetsier PM; Kingma WP; Kuiper MA; Ince C
    Crit Care Med; 2010 Jan; 38(1):93-100. PubMed ID: 19730258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
    Annane D; Sébille V; Charpentier C; Bollaert PE; François B; Korach JM; Capellier G; Cohen Y; Azoulay E; Troché G; Chaumet-Riffaud P; Bellissant E
    JAMA; 2002 Aug; 288(7):862-71. PubMed ID: 12186604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
    Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
    Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
    Keh D; Trips E; Marx G; Wirtz SP; Abduljawwad E; Bercker S; Bogatsch H; Briegel J; Engel C; Gerlach H; Goldmann A; Kuhn SO; Hüter L; Meier-Hellmann A; Nierhaus A; Kluge S; Lehmke J; Loeffler M; Oppert M; Resener K; Schädler D; Schuerholz T; Simon P; Weiler N; Weyland A; Reinhart K; Brunkhorst FM;
    JAMA; 2016 Nov; 316(17):1775-1785. PubMed ID: 27695824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
    Angstwurm MW; Engelmann L; Zimmermann T; Lehmann C; Spes CH; Abel P; Strauss R; Meier-Hellmann A; Insel R; Radke J; Schüttler J; Gärtner R
    Crit Care Med; 2007 Jan; 35(1):118-26. PubMed ID: 17095947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.
    Keh D; Boehnke T; Weber-Cartens S; Schulz C; Ahlers O; Bercker S; Volk HD; Doecke WD; Falke KJ; Gerlach H
    Am J Respir Crit Care Med; 2003 Feb; 167(4):512-20. PubMed ID: 12426230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.
    Schmoelz M; Schelling G; Dunker M; Irlbeck M
    J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
    Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
    JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.